Global Custom Market Research Reports Provider Company

phone

Interface Biologics Inc - Product Pipeline Analysis, 2018 Update

  • Published Date: 05 Jul 2018
  • Number of Pages: 20
  • Category: Company Profile
  • Country: Canada
Summary

Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery platforms. IBIs technologies include endexo, kinesyx and epidel. The company provides combination drug delivery devices which include Epidel and Kinesyx. Its products improve the safety and effectiveness of implantable medical devices. The company serves dialysis patients in Canada and abroad. IBI is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Interface Biologics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy
:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 3
List of Figures 3
Interface Biologics Inc Company Overview 4
Interface Biologics Inc Company Snapshot 4
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Interface Biologics Inc Pipeline Analysis Overview 6
Interface Biologics Inc - Key Facts 6
Interface Biologics Inc - Major Products and Services 7
Interface Biologics Inc Pipeline Products by Development Stage 8
Interface Biologics Inc Pipeline Products Overview 9
EPICUFF 9
EPICUFF Product Overview 9
EPISCREW - Dental Implant 10
EPISCREW - Dental Implant Product Overview 10
EPISCREW - Orthopedic Fixation Device 11
EPISCREW - Orthopedic Fixation Device Product Overview 11
Interface Biologics Inc - Key Competitors 12
Interface Biologics Inc - Key Employees 13
Interface Biologics Inc - Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Interface Biologics Inc, Recent Developments 15
Feb 14, 2011: Interface Biologics Appoints Art Rosenthal To Chairman Of Board Of Directors 15
Oct 26, 2010: Interface Biologics Receives ISO 13485:2003 Certification 15
Dec 09, 2008: Interface Appoints President And Board Member 15
Aug 25, 2007: Interface Appoints New Advisory Board Member 16
May 08, 2007: Interface Appoints New Advisory Board Member 16
Appendix 17
Methodology 17
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables

List of Tables
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Interface Biologics Inc Pipeline Products by Equipment Type 5
Interface Biologics Inc Pipeline Products by Indication 5
Interface Biologics Inc, Key Facts 6
Interface Biologics Inc, Major Products and Services 7
Interface Biologics Inc Number of Pipeline Products by Development Stage 8
Interface Biologics Inc Pipeline Products Summary by Development Stage 8
EPICUFF - Product Status 9
EPICUFF - Product Description 9
EPISCREW - Dental Implant - Product Status 10
EPISCREW - Dental Implant - Product Description 10
EPISCREW - Orthopedic Fixation Device - Product Status 11
EPISCREW - Orthopedic Fixation Device - Product Description 11
Interface Biologics Inc, Key Employees 13
Glossary 19

List Of Figures

List of Figures
Interface Biologics Inc Pipeline Products by Equipment Type 5
Interface Biologics Inc Pipeline Products by Development Stage 8

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products

View Report

Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as

View Report

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The companys product portfolio includes molecular

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports